KalVista Pharmaceuticals (KALV) Payables (2014 - 2025)
KalVista Pharmaceuticals recorded quarterly Payables of $5.9 million in Q3 2025, up 20.19% quarter-over-quarter from $4.9 million in Q2 2025, and down 45.62% year-over-year from $10.8 million in Q3 2024.
KalVista Pharmaceuticals' Payables history runs 12 years deep, the most recent figure standing at $5.9 million for Q3 2025.
- In Q3 2025, Payables fell 45.62% year-over-year to $5.9 million; the TTM figure through Jul 2025 stood at $5.9 million (down 45.62% YoY), while the FY2025 annual figure was $4.9 million, down 46.38% from the prior year.
- Payables came in at $5.9 million for Q3 2025 at KalVista Pharmaceuticals, up from $4.9 million in the prior quarter.
- In the past five years, Payables ranged from a high of $10.8 million in Q3 2024 to a low of $641000.0 in Q1 2021.
- A 5-year average of $4.2 million and a median of $3.6 million in 2022 frame the typical range for Payables.
- Across the five-year window, Payables plunged 78.28% in 2021 and jumped 240.87% in 2022, its largest moves.
- KalVista Pharmaceuticals' Payables stood at $3.2 million in 2021, then grew by 7.12% to $3.4 million in 2022, then soared by 44.68% to $4.9 million in 2023, then increased by 16.95% to $5.7 million in 2024, then advanced by 2.5% to $5.9 million in 2025.
- According to Business Quant data, Payables over the past three periods registered $5.9 million, $4.9 million, and $5.7 million for Q3 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 300,549.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.05 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 83.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 10.62 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 8.69 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 489.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.03 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 126.63 Mn |
| 10 | KalVista Pharmaceuticals | 1.44 Bn | 1.25 Bn | 56.41 Mn | 5.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | 5.87 Mn |
| Apr 30, 2025 | 4.88 Mn |
| Dec 31, 2024 | 5.73 Mn |
| Oct 31, 2024 | 5.20 Mn |
| Jul 31, 2024 | 10.79 Mn |
| Apr 30, 2024 | 9.11 Mn |
| Jan 31, 2024 | 3.10 Mn |
| Oct 31, 2023 | 4.90 Mn |
| Jul 31, 2023 | 5.06 Mn |
| Apr 30, 2023 | 4.82 Mn |
| Jan 31, 2023 | 1.70 Mn |
| Oct 31, 2022 | 3.38 Mn |
| Jul 31, 2022 | 2.91 Mn |
| Apr 30, 2022 | 3.64 Mn |
| Jan 31, 2022 | 2.19 Mn |
| Oct 31, 2021 | 3.16 Mn |
| Jul 31, 2021 | 1.45 Mn |
| Apr 30, 2021 | 1.98 Mn |
| Jan 31, 2021 | 641,000.00 |
| Oct 31, 2020 | 2.17 Mn |
| Jul 31, 2020 | 1.77 Mn |
| Apr 30, 2020 | 1.68 Mn |
| Jan 31, 2020 | 2.95 Mn |
| Oct 31, 2019 | 2.24 Mn |
| Jul 31, 2019 | 3.10 Mn |
| Apr 30, 2019 | 2.86 Mn |
| Jan 31, 2019 | 3.00 Mn |
| Oct 31, 2018 | 3.02 Mn |
| Jul 31, 2018 | 2.35 Mn |
| Apr 30, 2018 | 1.43 Mn |
| Jan 31, 2018 | 1.58 Mn |
| Oct 31, 2017 | 1.04 Mn |
| Jul 31, 2017 | 1.94 Mn |
| Apr 30, 2017 | 1.15 Mn |
| Jan 31, 2017 | 755,000.00 |
| Mar 31, 2016 | 793,000.00 |
| Dec 31, 2015 | 1.46 Mn |
| Sep 30, 2015 | 1.53 Mn |
| Jun 30, 2015 | 1.99 Mn |
| Mar 31, 2015 | 8.07 Mn |
| Dec 31, 2014 | 1.02 Mn |